Product Reports Resources Pricing Login Book a demo

Phil

Biotech & Life Sciences · San Francisco, United States · Founded 2015

End-to-end prescription management and delivery service connecting patients with local pharmacies MoreLess

Phil.us is a healthcare technology startup that aims to revolutionize the way patients access their medications. The company operates in the healthcare and pharmaceutical markets, serving both healthcare providers (HCPs) and patients. Its primary offering is the PhilRx platform, a digital tool designed to streamline the process of obtaining prescribed medications.

The platform's main features include a national dispense network, real-time HIPAA compliant data, and actionable insights. It simplifies the prior authorization process, ensuring that patients can start their therapy without delay. By negotiating formulary access, Phil.us guarantees that prescriptions are covered by insurance, reducing the financial burden on patients.

The company's business model is centered around improving patient adherence to medication regimens and increasing the number of prescriptions covered by insurance. This is achieved by removing barriers to medication access and providing a seamless experience for both patients and healthcare providers.

Phil.us also offers consulting services to help healthcare providers optimize their channel strategies and build effective telemedicine programs. These services aim to improve patient access and drive transformative brand outcomes.

In terms of revenue generation, Phil.us likely makes money through a combination of platform subscription fees from healthcare providers, consultation fees, and possibly a percentage from each prescription filled through their platform.

In conclusion, Phil.us is a promising startup that leverages technology to simplify medication access and improve patient outcomes in the healthcare sector.

Keywords: Healthcare Technology, Patient Access, Medication Adherence, Prescription Coverage, Prior Authorization, Telemedicine, Consulting Services, HIPAA Compliant Data, Pharmaceutical Market, National Dispense Network.

Company overview

Phil company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2015
Headquarters
San Francisco, United States
Employees
284
Open positions
15
Dealroom signal
83.7
client focusb2csub industryPharmaceuticalsub industryHealth PlatformindustryHealthsectorPharmacysectorBiotechnologysectorPatient CaresectorBiotech and PharmasectorHard TechsectorDT and LSsectorscience-based

Valuation & funding

Phil funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBTDebt Jul 2025 $60M K2 HealthVentures
SERIES DOther financing Jun 2021 $56M $224M Warburg Pincus
SERIES BOther financing May 2019 $25M $100M Uncork Capital · Tarsadia Investments · GreatPoint Ventures · Crosslink Capital
SERIES BOther financing Jun 2018 $0 FJ Labs
SERIES AOther financing Aug 2017 $10M $40M Silicon Valley Bank · SV Angel · Uncork Capital · Tom Williams
EARLY VCOther financing Nov 2016 Undisclosed
SEEDOther financing Aug 2015 Jose Marin · Forerunner Ventures · Tom Williams · Fabrice Grinda
Showing 7 recorded eventsUnlock the complete deal history →

Growth signals

Phil website traffic

Latest recorded traffic for Phil is 330K monthly website visits, up 3.1% over the last three months. Phil's team declined 1.4% over the past year.

Latest monthly visits330K 3-month web change+3.1% 1-year team growth-1.4%
Monthly website visits112 observations · Jan 2017–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Phil compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Phil's talent

Book a demo to see the people
Team profiled 21 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

16 investors on Phil's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 9 investors entered at this stage
Series A 5 investors entered at this stage
Crosslink Capital
Silicon Valley Bank
Transmedia Capital
GreatPoint Ventures
Tarsadia Investments
Series B+ 2 investors entered at this stage
Warburg Pincus
K2 HealthVentures

Global footprint

Where Phil has talent and traffic

Workforce by country
9 countries with
team presence
🇺🇸 United States93.2%
🇵🇭 Philippines1.9%
🇮🇳 India1.2%
🇨🇦 Canada0.6%
🇲🇽 Mexico0.6%
Top 5 of 9 shown

In the news

Latest news about Phil

Recent press, funding announcements, and product moves mentioning Phil — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Phil

An AI-synthesized read of the highest-engagement posts about Phil on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Phil’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.